Clinical effect of lymphocyte immunotherapy on patients with unexplained recurrent spontaneous abortion

Abstract Introduction Lymphocyte immunotherapy (LIT) is believed to be a viable treatment for unexplained recurrent spontaneous abortion (URSA), but its effect remains controversial. This study aims to investigate the clinical effect of LIT in patients with URSA and clarify the factors that may infl...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Sudong Liu, Xiaodong Gu, Ruiqiang Weng
Formato: article
Lenguaje:EN
Publicado: Wiley 2021
Materias:
Acceso en línea:https://doaj.org/article/f56433f4d85b4e2ab3a9d3eb2ba68e6c
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:f56433f4d85b4e2ab3a9d3eb2ba68e6c
record_format dspace
spelling oai:doaj.org-article:f56433f4d85b4e2ab3a9d3eb2ba68e6c2021-11-12T19:57:14ZClinical effect of lymphocyte immunotherapy on patients with unexplained recurrent spontaneous abortion2050-452710.1002/iid3.474https://doaj.org/article/f56433f4d85b4e2ab3a9d3eb2ba68e6c2021-12-01T00:00:00Zhttps://doi.org/10.1002/iid3.474https://doaj.org/toc/2050-4527Abstract Introduction Lymphocyte immunotherapy (LIT) is believed to be a viable treatment for unexplained recurrent spontaneous abortion (URSA), but its effect remains controversial. This study aims to investigate the clinical effect of LIT in patients with URSA and clarify the factors that may influence the outcome of LIT. Methods This study included a total of 704 URSA patients, of which 444 patients accepted LIT treatment. URSA patients that did not accept LIT served as control group. Clinical characteristics were collected and analyzed between LIT and control group. The blocking antibody was tested before and after LIT. The outcome of LIT treatment was recorded. Logistic regression analysis was applied to evaluate the independent predictors of LIT success. Results After LIT treatment, 77.9% (346/444) of USRA patients turned to BA positive, and the conversion rate elevated with increased LIT (p < .001). LIT significantly improved the pregnancy rate and live birth rate in USRA patients (65.3% vs. 29.6%, p < .001; 80.3% vs. 50.6%, p < .001). Multivariate regression analysis suggested that younger maternal age and positive BA were independent predictors of LIT success. Conclusion LIT effectively induced the production of BA, and improved pregnancy rate and live birth rate in URSA patients. Our findings supported LIT as a beneficial treatment for URSA.Sudong LiuXiaodong GuRuiqiang WengWileyarticleblocking antibody (BA)live birth ratelymphocyte immunotherapy (LIT)unexplained recurrent spontaneous abortion (URSA)Immunologic diseases. AllergyRC581-607ENImmunity, Inflammation and Disease, Vol 9, Iss 4, Pp 1272-1278 (2021)
institution DOAJ
collection DOAJ
language EN
topic blocking antibody (BA)
live birth rate
lymphocyte immunotherapy (LIT)
unexplained recurrent spontaneous abortion (URSA)
Immunologic diseases. Allergy
RC581-607
spellingShingle blocking antibody (BA)
live birth rate
lymphocyte immunotherapy (LIT)
unexplained recurrent spontaneous abortion (URSA)
Immunologic diseases. Allergy
RC581-607
Sudong Liu
Xiaodong Gu
Ruiqiang Weng
Clinical effect of lymphocyte immunotherapy on patients with unexplained recurrent spontaneous abortion
description Abstract Introduction Lymphocyte immunotherapy (LIT) is believed to be a viable treatment for unexplained recurrent spontaneous abortion (URSA), but its effect remains controversial. This study aims to investigate the clinical effect of LIT in patients with URSA and clarify the factors that may influence the outcome of LIT. Methods This study included a total of 704 URSA patients, of which 444 patients accepted LIT treatment. URSA patients that did not accept LIT served as control group. Clinical characteristics were collected and analyzed between LIT and control group. The blocking antibody was tested before and after LIT. The outcome of LIT treatment was recorded. Logistic regression analysis was applied to evaluate the independent predictors of LIT success. Results After LIT treatment, 77.9% (346/444) of USRA patients turned to BA positive, and the conversion rate elevated with increased LIT (p < .001). LIT significantly improved the pregnancy rate and live birth rate in USRA patients (65.3% vs. 29.6%, p < .001; 80.3% vs. 50.6%, p < .001). Multivariate regression analysis suggested that younger maternal age and positive BA were independent predictors of LIT success. Conclusion LIT effectively induced the production of BA, and improved pregnancy rate and live birth rate in URSA patients. Our findings supported LIT as a beneficial treatment for URSA.
format article
author Sudong Liu
Xiaodong Gu
Ruiqiang Weng
author_facet Sudong Liu
Xiaodong Gu
Ruiqiang Weng
author_sort Sudong Liu
title Clinical effect of lymphocyte immunotherapy on patients with unexplained recurrent spontaneous abortion
title_short Clinical effect of lymphocyte immunotherapy on patients with unexplained recurrent spontaneous abortion
title_full Clinical effect of lymphocyte immunotherapy on patients with unexplained recurrent spontaneous abortion
title_fullStr Clinical effect of lymphocyte immunotherapy on patients with unexplained recurrent spontaneous abortion
title_full_unstemmed Clinical effect of lymphocyte immunotherapy on patients with unexplained recurrent spontaneous abortion
title_sort clinical effect of lymphocyte immunotherapy on patients with unexplained recurrent spontaneous abortion
publisher Wiley
publishDate 2021
url https://doaj.org/article/f56433f4d85b4e2ab3a9d3eb2ba68e6c
work_keys_str_mv AT sudongliu clinicaleffectoflymphocyteimmunotherapyonpatientswithunexplainedrecurrentspontaneousabortion
AT xiaodonggu clinicaleffectoflymphocyteimmunotherapyonpatientswithunexplainedrecurrentspontaneousabortion
AT ruiqiangweng clinicaleffectoflymphocyteimmunotherapyonpatientswithunexplainedrecurrentspontaneousabortion
_version_ 1718430350131068928